Cymabay Therapeutics Inc (NASDAQ:CBAY)

3.77
Delayed Data
As of Nov 26
 -0.03 / -0.79%
Today’s Change
3.39
Today|||52-Week Range
7.77
-34.32%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 3
2018
Quarter 4
2018
Quarter 1
2019
Quarter 2
2019
Revenue and IncomeNet Revenues0.000.000.000.00--
Depreciation And Amortization14.0K66.0K138.0K140.0K
 
 
 
 
 
 
Operating ExpensesGross Income-14.0K-66.0K-138.0K-140.0K
 
 
 
 
 
General Expenses21.1M20.5M24.1M25.5M
 
 
 
 
 
Research And Development17.9M16.4M18.6M21.1M
 
 
 
 
 
Total Operating Expenses21.1M20.6M24.3M25.6M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-21.1M-20.6M-24.3M-25.6M
 
 
 
 
 
Extraordinary Credit1.5M0.000.000.00
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-18.6M-19.4M-23.1M-24.0M
 
 
 
 
 
Net Income-18.6M-19.4M-23.1M-24.0M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS59.1M59.4M61.9M68.7M
 
 
 
 
 
Shares To Calculate EPS Diluted59.4M59.4M61.9M68.7M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.34-$0.32-$0.37-$0.35
 
 
 
 
 
EPS Diluted-$0.34-$0.33-$0.37-$0.35